Confusable diagnoses · PANCE / PANRE

Gastroesophageal Reflux Disease vs Peptic Ulcer Disease

Gastroesophageal Reflux Disease and Peptic Ulcer Disease are easy to mix up on the boards. Here's a side-by-side comparison — presentation, workup, imaging, and first-line treatment — drawn from our full outlines.

Gastroesophageal Reflux Disease vs Peptic Ulcer Disease at a glance

  • Gastroesophageal Reflux Disease: Retrograde flow of gastric contents into the esophagus producing symptoms or mucosal injury.
  • Peptic Ulcer Disease: Mucosal break >5 mm in the stomach or duodenum, most often due to H. pylori or NSAIDs.

Try two board-style questions on Gastroesophageal Reflux Disease vs Peptic Ulcer Disease

Real questions from the FirstPassPA bank, with the full explanation. Pick an answer — no signup, no email.

Question 1GastrointestinalMedium
A 55-year-old woman with chronic GERD on omeprazole 20 mg once daily, which she takes at bedtime, has persistent heartburn and regurgitation after 8 weeks of therapy. She has no dysphagia, weight loss, or anemia. Upper endoscopy shows Los Angeles Grade B erosive esophagitis. Which of the following is the most appropriate next step in management?
  • AAdd oral sucralfate four times daily
  • BRefer for laparoscopic Nissen fundoplication
  • CIncrease omeprazole to twice daily before meals
  • DOrder ambulatory 24-hour pH-impedance testing
  • ESwitch omeprazole to oral famotidine
Reveal answer & full explanation
Correct answer: C — Increase omeprazole to twice daily before meals
  • AAdd oral sucralfate four times daily
  • BRefer for laparoscopic Nissen fundoplication
  • CIncrease omeprazole to twice daily before meals✓
  • DOrder ambulatory 24-hour pH-impedance testing
  • ESwitch omeprazole to oral famotidine

Why Increase omeprazole to twice daily before meals is correct

  • This patient has endoscopically confirmed erosive esophagitis (Los Angeles Grade B) with an inadequate response to once-daily PPI
  • Proton pump inhibitors bind irreversibly only to actively secreting pumps, so they must be taken 30 to 60 minutes before a meal
  • She is currently dosing at bedtime, which is suboptimal timing
  • Increasing to twice daily and dosing before meals corrects both the dose and the timing and is the appropriate next step
  • Optimizing PPI therapy precedes any escalation to advanced testing or surgery

Why the others are wrong

  • Add oral sucralfate four times daily — right-concept-wrong-setting: sucralfate is a mucosal coating agent with minimal benefit in erosive esophagitis and does not address the inadequate acid suppression. ACG 2022 does not recommend sucralfate for GERD except during pregnancy.
  • Switch omeprazole to oral famotidine — confused-with step-up: replacing the PPI with an H2 receptor antagonist (H2RA) is a step down, not up, in acid suppression; H2RAs are less effective than PPIs for healing erosive esophagitis and are prone to tachyphylaxis. A bedtime H2RA has only a limited, as-needed add-on role for nocturnal symptoms despite a PPI.
  • Refer for laparoscopic Nissen fundoplication — premature-escalation: she has taken omeprazole only once daily at bedtime, so her persistent symptoms do not make her PPI-refractory, and optimizing PPI therapy comes first; antireflux surgery is an option for long-term treatment of objectively confirmed GERD, with the best results in patients whose typical symptoms respond to PPIs. Before any antireflux procedure, ambulatory reflux monitoring should confirm that persistent symptoms are reflux-related, and high-resolution manometry is needed to exclude achalasia or absent contractility.
  • Order ambulatory 24-hour pH-impedance testing — tempting for persistent symptoms on a PPI, but LA Grade B esophagitis already confirms GERD, so reflux testing would not change management yet; on-therapy pH-impedance testing is used when symptoms persist despite correctly timed twice-daily PPI, and her PPI dosing and timing have not yet been optimized

Additional high-yield points

  • If symptoms persisted despite correctly dosed twice-daily PPI, ambulatory pH-impedance testing on therapy would be the next investigation
Question 2GastrointestinalMedium
A 47-year-old man with heavy NSAID use has epigastric pain and melena. Which of the following complications is most likely?
  • APenetration into the pancreas
  • BGastric outlet obstruction
  • CFree perforation with peritonitis
  • DLower gastrointestinal hemorrhage
  • EUpper gastrointestinal hemorrhage
Reveal answer & full explanation
Correct answer: E — Upper gastrointestinal hemorrhage
  • APenetration into the pancreas
  • BGastric outlet obstruction
  • CFree perforation with peritonitis
  • DLower gastrointestinal hemorrhage
  • EUpper gastrointestinal hemorrhage✓

Why Upper gastrointestinal hemorrhage is correct

  • NSAIDs impair prostaglandin-mediated mucosal defense, causing peptic ulcers that erode into submucosal vessels.
  • Melena (black, tarry stool) signals a bleeding source proximal to the ligament of Treitz, classic for a bleeding duodenal or gastric ulcer.

Why the others are wrong

  • Lower gastrointestinal hemorrhage — A lower-tract source typically produces hematochezia, not melena; the black tarry stool points upstream (anchoring on the word bleeding).
  • Gastric outlet obstruction — Chronic ulcer scarring can obstruct, but that causes early satiety and succussion-splash vomiting, not melena (right-disease-wrong-complication).
  • Free perforation with peritonitis — Perforation produces sudden rigid abdomen and pneumoperitoneum, not melena; bleeding and perforation are distinct ulcer complications (premature closure on severity).
  • Penetration into the pancreas — Penetration, usually of a posterior duodenal ulcer into the pancreas, is a classic ulcer complication, but it typically changes the pain to constant, severe pain radiating to the back and does not by itself explain melena; the black, tarry stool points to bleeding (anchoring on the ulcer rather than the presentation).

That's 2 of 7,700+. Get the rest.

Unlock the full FirstPassPA bank: 7,700+ board-style questions, flashcards, and an AI tutor that explains every answer. Your 7-day free trial includes everything, and there's no credit card required.

Start your 7-day free trial →
🔒 Free preview limit reached

Keep comparing — start your free trial

You've used your 2 free previews. Create your free account to see the full Gastroesophageal Reflux Disease vs Peptic Ulcer Disease comparison — plus all 514 diagnosis outlines, 7,700+ board-style questions, and an AI tutor. Your 7-day free trial includes everything, no credit card required.

Free to start · No credit card · Cancel anytime

Side-by-side comparison

FeatureGastroesophageal Reflux DiseasePeptic Ulcer Disease
At a glanceRetrograde flow of gastric contents into the esophagus producing symptoms or mucosal injury.Mucosal break >5 mm in the stomach or duodenum, most often due to H. pylori or NSAIDs.
Classic presentationPostprandial retrosternal burning relieved by antacids; nocturnal symptoms relieved by elevating the head of the bed.; Heartburn — retrosternal burning, worse postprandially or supine; Regurgitation of sour/bitter material; Dysphagia (suggests stricture, eosinophilic esophagitis, or malignancy if progressive); Water brash…Duodenal: pain relieved by eating. Gastric: pain provoked by eating.; Epigastric pain — burning, gnawing, or hunger-like; Duodenal ulcer: pain 2-3 h after meals, relieved by food or antacids, nocturnal awakening; Gastric ulcer: pain worsened by food, weight loss; Nausea, early satiety, bloating, belching; Hematemesis, melena, or…
Workup / key labsClinical diagnosis when classic heartburn/regurgitation respond to empiric PPI trial. Objective confirmation by erosive esophagitis (LA grade B, C, or D), biopsy-proven Barrett esophagus, or peptic stricture on EGD, or abnormal pH study (acid exposure time >6%) per Lyon Consensus 2.0; LA grade A alone is not conclusive.; No labs…CBC (anemia from chronic blood loss); BMP, LFTs; Type and screen / crossmatch if acute bleed; H. pylori testing: urea breath test or stool antigen (preferred non-invasive); biopsy-based rapid urease test or histology if EGD performed; Fasting gastrin level if Zollinger-Ellison suspected; Withhold PPI 2 weeks and antibiotics 4 weeks…
ImagingUpper endoscopy (EGD) indicated for alarm features (dysphagia, odynophagia, weight loss, GI bleeding, anemia, vomiting, age ≥60 with new symptoms) or symptoms refractory to 8 weeks of PPI; Ambulatory esophageal pH or pH-impedance monitoring — gold standard for confirming reflux when EGD is normal; performed off PPI for diagnosis or on…Upper endoscopy (EGD) — gold standard; visualizes ulcer, allows biopsy and therapeutic intervention; biopsy ALL gastric ulcers to exclude malignancy; Upright CXR — free air under diaphragm in perforation; CT abdomen with contrast if perforation or complication suspected
First-line treatmentLifestyle modification: weight loss if BMI elevated, elevate head of bed 6-8 inches, avoid recumbency for 3 h after meals, smoking and alcohol cessation, identify and remove dietary triggers; PPI — omeprazole, pantoprazole, esomeprazole — once daily 30-60 min before breakfast for 8 weeks; step-down to lowest effective dose after symptom…PPI — omeprazole, pantoprazole, esomeprazole — 4-8 weeks (8-12 weeks for gastric ulcer); H. pylori eradication if positive (see by_subtype); Discontinue NSAIDs and aspirin if possible; switch to acetaminophen; Lifestyle: smoking cessation, limit alcohol

Drill Gastroesophageal Reflux Disease vs Peptic Ulcer Disease questions on FirstPassPA

Turn this comparison into retention. 7,700+ board-style questions with an AI tutor that explains every answer — free to start, no card required.

Start your 7-day free trial → Get today's free question →

Educational use only. This outline is a study aid for PA students and is not medical advice or a substitute for clinical judgment. FirstPassPA is an independent study tool and is not affiliated with, endorsed by, or sponsored by NCCPA or PAEA. PANCE® and PANRE® are registered trademarks of the National Commission on Certification of Physician Assistants; End of Rotation™ is a program of the Physician Assistant Education Association.